Advances in Comprehensive Management Strategies for Inflammatory Bowel Disease

Dear Colleagues,

The management of inflammatory bowel disease (IBD) is a rapidly evolving field, driven by continuous advancements in diagnostics, therapeutics, and our understanding of disease pathogenesis. With the rising global incidence and prevalence of IBD, particularly in newly industrialized countries, there is an increasing demand for up-to-date, evidence-based care. The introduction of biologic agents and small molecule therapies has significantly expanded treatment options, offering targeted approaches to achieve sustained remission and mucosal healing. Alongside therapeutic innovation, there has been progress in disease monitoring, including the use of biomarkers, imaging, and endoscopic technologies to personalize treatment strategies. Emerging trends such as early intervention, treat-to-target strategies, and the integration of artificial intelligence in clinical decision-making are reshaping the standard of care. Moreover, there is growing recognition of the importance of holistic, multidisciplinary approaches that address not only inflammation but also quality of life, nutrition, mental health, and disease complications. For specialists, staying up-to-date with these developments is essential to delivering optimal patient care. This requires ongoing education, engagement with the latest clinical research, and participation in guideline updates and professional networks. As the landscape of IBD management continues to shift, a commitment to continuous learning and adaptation ensures that clinicians remain equipped to offer the most effective and individualized treatments.

We are pleased to invite you to contribute to this Topic Collection: “Advances in Comprehensive Management Strategies for Inflammatory Bowel Disease.”

This Topic aims to provide an update on the rapidly evolving field of management of IBD.

In this Topic, original research articles and reviews are welcome. Research areas may include (but not limited to) the following:

1. The burden of disability in IBD;
2. The genetic predisposition to IBD;
3. How to improve patients’ adherence and compliance;
4. Wearable devices to monitor IBD;
5. How to provide an adequate screening and surveillance for colorectal cancer;
6. Environmental risk factors for IBD;
7. Role of diet in prevention or provoking IBD;
8. Role of diet and balanced nutrition in the management of IBD.

We look forward to receiving your contributions.

Prof. Dr. Vito Annese
Prof. Dr. Vincenzo Villanacci
Prof. Dr. Fabiana Castiglione
Dr. Ferdinando D'Amico
Dr. Flavio Caprioli
Topic Editors